Menu
340B covered entities are worried that Humana may begin widespread rejection of claims for prescriptions filled with 340B drugs, and may begin auditing 340B claims more aggressively.

Providers Worried About Humana’s 340B Claims ID and Data-Reporting Conditions

In Other Industry, Regulatory Tom Mirga
Health insurance company Humana has begun sending pharmacy provider agreements for 2022 to 340B-participating pharmacies, with claims-identification and data-reporting conditions that some 340B providers say are unsettling. They say the agreements are to be signed and returned within 30 days of receipt.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.